The DCGI’s proposed rules will require pills such as Unwanted-72 and i-pill to carry QR-linked warnings and detailed guidance ...
India Today on MSN
India's drug panel seeks strict warning labels on morning-after pills
The Drug Consultative Committee of the Central Drug Standard Control Organisation (CDSCO) also advised adding a clear warning ...
In a move aimed at streamlining regulatory clarity and improving access to essential reproductive health products, the Drugs ...
India’s top drug regulator is considering new mandatory warning labels for morning-after pills, advising limited use and clearer guidance on risks and alternatives.
Onlymyhealth on MSN
Hidden Cost of Emergency Contraceptives: Expert Shares What Women Need to Know Before Reaching for Morning-After Pills
Emergency contraception is safe for occasional use but regular use can disrupt your cycle and mask health problems increasing risks Read ahead to know what doctors want women to know ...
Opinion Contributor Dr. Norman Wang (McCormick '94 Feinberg '98) responds to two Daily op-eds concerning emergency ...
The rise of GLP-1 drugs such as Ozempic and Mounjaro has been nothing short of meteoric. Originally developed to treat ...
The most common side effects of GLP-1 medicines are related to digestion: nausea, vomiting, diarrhoea, indigestion, stomach ...
HIV-positive women have multiple safe birth-control options, but drug interactions, viral load and treatment stability still ...
Analysis has found a link between semaglutide use and suicidal thoughts but not all evidence supports these findings ...
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced the European Patent Office (EPO) has issued patent No. 4 496 611 titled, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results